Key takeaways
- Insurance stocks are quietly compounding: Canadian insurers have been putting up strong returns thanks to higher interest rates boosting investment income and disciplined underwriting, making this one of the more overlooked corners of the Canadian market right now.
- Different flavors for different portfolios: This group covers real range, from Fairfax Financial’s value-driven, Berkshire-style approach to Manulife’s massive wealth management pivot in Asia, to Trisura’s specialty niche that’s been a growth standout among smaller names.
- Rate sensitivity cuts both ways: The same rising rate environment that’s been padding earnings could reverse if central banks start cutting aggressively, and any prolonged economic slowdown would pressure premium growth and claims experience across the board, so don’t treat these as set-and-forget holdings.
Canadian insurance stocks have been on an absolute tear. Manulife, Fairfax, Great-West, Sun Life, Intact, even smaller names like Trisura. The returns over the past few years have been genuinely impressive across the board, and it’s not hard to see why. Higher interest rates juiced investment income. Underwriting discipline improved. And several of these companies used the cycle to aggressively buy back shares and grow dividends.
So the obvious question: is the easy money already made?
I don’t think so, but the setup has changed. Rate cuts are underway, which means the investment income tailwind that turbocharged earnings is fading. That doesn’t kill the thesis for these companies, but it does mean you need to be pickier about which ones you own. A rising tide lifted all boats over the past two years. That’s not the environment we’re heading into. The gap between well-run insurers and mediocre ones is going to widen, and paying attention to fundamentals matters more now than it did twelve months ago.
What I find compelling about insurance as a sector is how different the business models are under the same label. You’ve got life insurers with massive wealth management arms that look more like Canadian bank stocks than traditional insurance companies. You’ve got P&C insurers where underwriting discipline is everything. And you’ve got specialty players writing niche lines of business with totally different risk profiles. Comparing them apples to apples doesn’t work.
That variety is actually a strength for portfolio construction. If you already own Canadian dividend stocks concentrated in banks and pipelines, insurers give you financial sector exposure with different earnings drivers. The correlation isn’t as tight as most people assume.
I focused on balance sheet quality, earnings consistency, and whether the current valuation still gives you a reasonable margin of safety. Some of these names have run hard enough that the risk/reward has shifted. Others still look attractive even after big moves.
In This Article
- Trisura Group Ltd. (TSU.TO)
- Manulife Financial Corporation (MFC.TO)
- Fairfax Financial Holdings Limited (FFH.TO)
- Great-West Lifeco Inc. (GWO.TO)
- Intact Financial Corporation (IFC.TO)
- Power Corporation of Canada (POW.TO)
Trisura Group Ltd. (TSX: TSU)
$41.61
Overall Grade6.2 / 10
Trisura Group Ltd. is a specialty property and casualty insurance company that operates primarily in Canada and the United States...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E13.8
P/B2.1
P/S0.6
P/FCF7.1
FCF Yield+14.0%
Growth & Outlook
Rev Growth (YoY)+0.9%
EPS Growth (YoY)+28.8%
Revenue 5yr+162.8%
EPS 5yr+20.1%
FCF 5yr-
Fundamentals
Market Cap$1.9B
Dividend Yield-
Operating Margin+37.6%
ROE+16.9%
Interest Coverage184.0x
Competitive Edge
- Trisura's fronting/program model in the US shifts underwriting risk to reinsurers while collecting fee income. This asset-light structure generates returns on equity without requiring Trisura to bear catastrophic loss exposure directly.
- Specialty surety and D&O/E&O lines in Canada have high barriers to entry: broker relationships, regulatory licensing, and claims expertise create switching costs. Competitors like Intact or Travelers focus on larger accounts, leaving Trisura's niche less contested.
- The dual-geography model (Canadian specialty underwriting plus US fronting programs) provides diversification without the capital intensity of building a traditional US carrier. Few sub-$2B insurers have this structure.
- Management's decision to pay zero dividends and reinvest all earnings is the correct capital allocation for a specialty insurer still scaling its US platform. Book value per share compounding at 16% ROE without dividend drag maximizes long-term intrinsic value.
By the Numbers
- FCF-to-net-income ratio of 1.88x signals strong earnings quality. For a specialty insurer, cash generation exceeding reported earnings by this margin suggests conservative reserve practices rather than aggressive income recognition.
- Interest coverage at 184.6x with net cash of $88M means Trisura has virtually zero financial distress risk. The $199M in total debt is dwarfed by operating earnings, giving management maximum flexibility to grow the book.
- SBC-to-revenue at 0.09% is negligible, and share count grew only 0.6% YoY. Combined with $19.4M in buybacks (0.9% yield), management is actually shrinking the float on a net basis. Rare discipline for a sub-$2B market cap insurer.
- EV/EBITDA of 1.6x looks anomalously cheap, but this reflects the insurance accounting reality where float and reserves inflate the balance sheet. Still, at 13x trailing earnings with 16% ROE, the stock prices in almost no premium for a specialty compounder.
- 5-year revenue CAGR of 172% versus 3-year CAGR of 4.7% shows the US Programs segment has scaled massively. EPS still grew 31% CAGR over 3 years, proving the top-line buildout is now converting to bottom-line compounding.
Risk Factors
- Net margin of 4.8% against an operating margin of 37.6% reveals a massive gap, likely driven by loss reserves, ceded premiums, and investment-related items. If loss development turns adverse, that thin net margin has very little cushion.
- Revenue growth decelerated sharply: 1.6% YoY versus 4.7% 3-year CAGR and 172% 5-year CAGR. The Growth grade of 4.8/10 confirms the hypergrowth phase from US Programs scaling is over. Future returns depend on underwriting quality, not top-line expansion.
- Risk grade of 4.3/10 and Returns grade of 3.4/10 together suggest the stock's risk-adjusted return profile has deteriorated. Despite decent absolute profitability, the market is not rewarding the earnings stream with a premium multiple.
- Debt paydown yield is negative at -3.2%, meaning Trisura is adding leverage. Combined with the 0.9% buyback yield, total shareholder yield is actually negative at -2.3%. Capital is flowing away from shareholders toward balance sheet expansion.
- ROA of 18.2% looks unusually high for an insurer and likely reflects how gross written premiums flow through the income statement before cessions. This metric is misleading here and should not be taken at face value.
Manulife Financial Corporation (TSX: MFC)
$59.92
Overall Grade5.8 / 10
Manulife Financial Corporation is a leading global financial services group providing life insurance, health insurance, and wealth management solutions. The company operates through several key segments: Insurance and Annuity Products, which offers individual life insurance, long-term care insurance, and group benefits; and Global Wealth and Asset Management, which provides mutual funds, exchange-traded funds, group retirement products, and institutional asset management services...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E15.5
P/B1.8
P/S1.7
P/FCF3.1
FCF Yield+32.4%
Growth & Outlook
Rev Growth (YoY)+18.1%
EPS Growth (YoY)+18.7%
Revenue 5yr+3.8%
EPS 5yr+0.3%
FCF 5yr+46.2%
Fundamentals
Market Cap$99.8B
Dividend Yield3.2%
Operating Margin+50.8%
ROE+13.3%
Interest Coverage21.6x
Competitive Edge
- Manulife's Asia distribution network across Hong Kong, Japan, Vietnam, and mainland China (via Manulife-Sinochem) creates a structural advantage that Western peers like MetLife and Prudential Financial cannot easily replicate. Agency force scale in these markets takes decades to build.
- The IFRS 17 transition has reset the earnings baseline, and Manulife's early adoption positions it ahead of peers in investor communication. The contractual service margin (CSM) backlog provides forward earnings visibility that traditional insurance accounting never offered.
- WAM's Manulife Investment Management platform manages C$808B across public and private markets, including timber and agriculture. These alternative asset capabilities command higher fees and stickier mandates than traditional fixed income, creating a differentiated asset management franchise.
- Manulife Bank of Canada provides direct-to-consumer banking that cross-sells into the insurance client base, a distribution synergy that pure-play insurers like Sun Life or Great-West lack. This integrated model improves customer lifetime value and retention.
- Asia's rising middle class and underpenetration of life insurance (protection gap exceeding US$80T across the region) provide a multi-decade secular tailwind. Manulife's top-3 market positions in Hong Kong, Vietnam, and Singapore place it directly in the path of this demand growth.
By the Numbers
- Asia APE sales grew 20.9% YoY to C$7.3B in FY2025, accelerating from 35.9% the prior year, now comprising 75% of total APE sales. This geographic mix shift toward Asia's higher-margin insurance products is structurally improving the consolidated expense efficiency ratio, which dropped from 48.9% in FY2021 to 44.8%.
- Total AUM reached C$1.38T with WAM segment generating C$2.25B in pre-tax income at a 30.4% margin on C$7.4B revenue. WAM pre-tax income grew at a 14.9% CAGR over three years, creating a fee-based earnings stream that reduces sensitivity to insurance reserve volatility.
- PEG ratio of 0.64 with forward P/E of 13.3x against consensus EPS growth from C$3.07 trailing to C$4.47 estimated (46% jump) signals the market is not fully pricing the IFRS 17 earnings normalization and Asia growth acceleration.
- Net debt is negative C$21B, meaning the company holds substantially more cash and investments than debt. Combined with 21.6x interest coverage, Manulife has significant balance sheet flexibility for capital returns and opportunistic M&A without needing to access debt markets.
- Share count declined 1.4% YoY with C$2.24B in buybacks, and the FCF payout ratio is just 11.1% versus an earnings payout ratio of 54.9%. This massive gap means the dividend is covered nearly 9x by free cash flow, leaving enormous room for buyback acceleration.
Risk Factors
- US segment swung to a C$527M net loss in FY2025 from C$135M profit in FY2024, a C$662M deterioration. US pre-tax income went from +C$132M to -C$708M, and the US expense efficiency ratio spiked from 24.5% to 32.9%, suggesting legacy long-term care or variable annuity reserve charges are resurfacing.
- Total AUM was essentially flat YoY at C$1.38T despite strong markets, with WAM AUM declining 0.1% and US AUM falling 6.2%. This stall after 14.8% growth the prior year suggests net outflows are offsetting market appreciation, a warning sign for fee revenue sustainability.
- ROE of 13.2% and ROIC of 2.8% reveal a wide gap, meaning most of the equity return is driven by financial leverage rather than operating efficiency. For a C$97B market cap insurer, sub-3% ROIC indicates the massive general account asset base generates thin spreads.
- Corporate and Other segment swung from C$81M net income to a C$88M loss, and its pre-tax income went from +C$335M to -C$314M. This C$649M pre-tax swing in a non-operating segment suggests hedging losses or one-time charges that management may be burying outside core segments.
- Canada APE sales declined 5.7% YoY in FY2025 after growing 19.9% the prior year. In the home market, this deceleration coincides with only 2% net income growth, suggesting the domestic insurance business is maturing and pricing competition is intensifying.
Fairfax Financial Holdings Limited (TSX: FFH)
$2,204.20
Overall Grade5.7 / 10
Fairfax Financial Holdings Limited is a diversified financial holding company whose core business is property and casualty (P&C) insurance and reinsurance. The company operates through a decentralized structure, with major insurance subsidiaries including Northbridge Financial (Canadian commercial P&C), Crum & Forster (U.S...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E8.0
P/B1.3
P/S0.8
P/FCF-53.9
FCF Yield-1.9%
Growth & Outlook
Rev Growth (YoY)+0.7%
EPS Growth (YoY)+3.4%
Revenue 5yr+8.1%
EPS 5yr+13.3%
FCF 5yr-14.1%
Fundamentals
Market Cap$46.1B
Dividend Yield0.9%
Operating Margin+17.2%
ROE+16.5%
Interest Coverage10.0x
Competitive Edge
- Prem Watsa's decentralized model, letting subsidiary CEOs run their own underwriting shops, creates accountability at the operating level that centralized insurers like AIG historically struggled with. Each unit owns its combined ratio.
- The Odyssey Group and Brit combination gives Fairfax access to both treaty reinsurance and Lloyd's specialty markets, two distribution channels that most competitors must choose between. This dual access creates pricing intelligence advantages.
- Geographic diversification across Canada, U.S., Asia, and international markets ($4.98B international net insurance revenue growing 10.5% YoY) provides natural catastrophe risk dispersion that pure domestic carriers cannot replicate.
- Fairfax's willingness to hold concentrated equity positions (historically Eurobank, Quess, IIFL) creates asymmetric upside that traditional insurers' conservative portfolios never capture. The non-insurance segment's 64.6% operating income growth reflects this.
- The IFRS 17 transition has made Fairfax's financials harder to compare with historical periods, creating a temporary analytical moat. Sophisticated investors who can bridge the accounting gap have an information edge over those who cannot.
By the Numbers
- Combined ratio improved from 95% in FY2021 to 92.7% in FY2024 before ticking up to 93% in FY2025. That sustained sub-95% performance across a $33B gross premium base generates over $1.8B in annual underwriting profit, a rare feat at this scale.
- Buyback yield of 9.2% with shares outstanding declining 2.1% YoY means management is aggressively retiring stock, not just offsetting SBC. At $3.16B in TTM repurchases versus only $184M in SBC, over 94% of buyback spend creates real per-share value.
- At 8.1x trailing P/E and 4.3x EV/EBITDA, the stock prices in zero growth despite 5Y EPS CAGR of 10.8%. Earnings yield of 12.3% versus a sub-1% dividend yield signals massive retained earnings compounding inside the business.
- International Insurers underwriting profit surged 111% YoY to $219M in FY2025, with the combined ratio likely dropping sharply as net premiums earned grew only 9.5%. This segment is inflecting from breakeven to meaningful contributor.
- Interest coverage at 10.8x is comfortable for a leveraged financial holding company. The investment portfolio is now generating substantial recurring income, with Global Insurers and Reinsurers alone producing $3.7B in operating income.
Risk Factors
- FCF-to-net-income conversion is deeply negative at -12.6%, and OCF-to-net-income is essentially zero at -0.6%. For an insurer, this likely reflects large investment portfolio movements distorting cash flow statements, but it makes traditional cash flow analysis nearly impossible.
- Global Insurers and Reinsurers operating income fell 14.2% YoY to $3.7B despite premiums earned growing 5%. The margin compression in Fairfax's largest segment, which drives over 55% of total operating income, is the single biggest earnings headwind.
- Life Insurance and Run-Off swung to a $214M operating loss in FY2025, a 132% deterioration YoY. This legacy book continues to be an unpredictable drag, and the $189M pre-tax loss suggests reserve strengthening or adverse development.
- Revenue declined 1.6% YoY on a trailing basis while analyst estimates project Y1 revenue of $31.8B, roughly a 37% drop from trailing $50.5B. This gap likely reflects reporting differences, but only 1 analyst covers revenue, creating an information vacuum.
- Specialty net insurance revenue declined 4.3% YoY after surging 49% the prior year. This boom-bust pattern in a segment that reached $2.5B suggests the growth was acquisition-driven rather than organic, raising integration and pricing discipline questions.
Great-West Lifeco Inc. (TSX: GWO)
$91.75
Overall Grade5.3 / 10
Great-West Lifeco Inc. is a leading international financial services holding company that provides a comprehensive suite of life and health insurance, retirement, and investment services...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E18.2
P/B2.6
P/S2.4
P/FCF10.5
FCF Yield+9.6%
Growth & Outlook
Rev Growth (YoY)+6.4%
EPS Growth (YoY)+24.0%
Revenue 5yr-11.0%
EPS 5yr+7.4%
FCF 5yr-
Fundamentals
Market Cap$81.5B
Dividend Yield2.9%
Operating Margin+17.7%
ROE+14.1%
Interest Coverage16.9x
Competitive Edge
- Empower Retirement (U.S. segment) is now the second-largest retirement plan recordkeeper in America after acquiring Prudential's full-service business. Scale advantages in recordkeeping create sticky, fee-based revenue with high switching costs for plan sponsors.
- Geographic diversification across Canada, U.S., Europe, and reinsurance provides natural hedging against regional regulatory changes, interest rate cycles, and mortality/morbidity trends. No single geography exceeds 40% of earnings.
- The Capital and Risk Solutions (reinsurance) segment provides counter-cyclical earnings diversification. Its 33.2% EBT growth in FY2025 offset weakness in Canada and Europe, demonstrating the portfolio effect management has built.
- Canada Life's dominant position in Canadian group benefits creates distribution lock-in through employer plan administration. Switching group insurers involves massive administrative friction, protecting retention rates above 90%.
- Parent Power Corporation's 72% ownership provides patient, long-term capital allocation discipline. This controlling shareholder structure insulates management from activist pressure and short-term market demands.
By the Numbers
- Total AUM surged 12.9% YoY to $1.14 trillion, reversing the prior year's 8.1% decline. This AUM recovery drives fee-based revenue and is the single most important leading indicator for earnings growth across all three operating geographies.
- U.S. segment pre-tax income has compounded at a blistering pace: $425M (FY2022) to $1.72B (FY2025), a 4x increase in three years. This segment now contributes 37% of consolidated EBT, up from roughly 10% in FY2022, fundamentally reshaping the earnings mix.
- Share count declined 3.7% YoY with $2.15B in TTM buybacks, producing a 2.5% buyback yield on top of the 2.9% dividend. Total shareholder yield of 5.4% is compelling for a company simultaneously growing EPS at a 19% 3-year CAGR.
- FCF payout ratio of 30% versus earnings payout ratio of 52% reveals strong cash conversion. FCF-to-net-income of 1.63x means reported earnings actually understate cash generation, a quality signal for an insurer.
- Net debt is negative at -$958M despite $8.97B in total debt, meaning cash and investments exceed borrowings. Interest coverage at 16.9x provides substantial cushion against rate volatility or credit market stress.
Risk Factors
- Europe net earnings dropped 34.5% YoY to $609M after an 81.6% surge the prior year, with Q-o-Q declines of 36% in the most recent quarter. This volatility suggests mark-to-market swings or reserve adjustments rather than stable underwriting income.
- Lifeco Corporate segment swung to -$495M pre-tax loss from -$39M prior year, a $456M deterioration. Revenue spiked to $915M (from $34M) while losses ballooned, suggesting one-time restructuring charges or hedging losses that need monitoring.
- Revenue has a negative 5-year CAGR of -12.4% and negative 10-year CAGR of -3.3%, partly due to IFRS 17 accounting distortions. Still, estimated Y1 revenue of only $5.2B versus trailing $32.3B signals analysts are using a completely different revenue definition, making top-line comparisons unreliable.
- ROIC of just 0.56% reflects the massive balance sheet ($862B+ in assets) typical of life insurers, but ROE of 14.1% is middling for the sector. With P/B at 2.58x, the market is pricing in ROE expansion that hasn't materialized yet.
- Canada segment pre-tax income fell 5.8% YoY and dropped 31.7% Q-o-Q in the latest quarter. As the largest earnings contributor at $1.84B, any sustained weakness here would disproportionately impact consolidated results.
Intact Financial Corporation (TSX: IFC)
$255.83
Overall Grade5.3 / 10
Intact Financial Corporation is a leading multinational property and casualty (P&C) insurance provider, operating primarily in Canada, the United States, the United Kingdom, and Ireland. In Canada, it is the largest P&C insurer, distributing products through a vast broker network, including its wholly-owned subsidiary BrokerLink, and directly to consumers under the belairdirect brand...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E15.7
P/B2.4
P/S1.9
P/FCF12.4
FCF Yield+8.1%
Growth & Outlook
Rev Growth (YoY)+2.3%
EPS Growth (YoY)+43.4%
Revenue 5yr+16.4%
EPS 5yr+9.4%
FCF 5yr+29.5%
Fundamentals
Market Cap$45.3B
Dividend Yield2.3%
Operating Margin+20.6%
ROE+16.1%
Interest Coverage26.7x
Competitive Edge
- Canada's P&C market is an oligopoly with high broker switching costs. IFC's 20%+ market share and ownership of BrokerLink creates a vertically integrated distribution advantage that competitors like Aviva Canada or Definity cannot easily replicate.
- The RSA acquisition gave IFC a specialty lines platform in the UK and Ireland with Lloyd's of London access. This diversifies catastrophe exposure away from Canadian weather events and provides access to hardening global specialty markets.
- IFC's data and AI capabilities in claims processing and pricing are a genuine cost advantage. Their investment in telematics and digital underwriting creates a feedback loop where better data leads to better risk selection, widening the gap against smaller regional carriers.
- Regulatory barriers in Canadian P&C insurance are significant. Provincial rate filing requirements, capital adequacy rules under OSFI, and the complexity of auto insurance regulation create a moat that deters new entrants and limits foreign competition.
- Management has a stated 10% NOIPS growth target and has consistently delivered through disciplined cycle management, buying market share during soft markets and harvesting during hard markets. This counter-cyclical playbook is rare and difficult to replicate.
By the Numbers
- Combined ratio improved from 94.2 in FY2023 to 88.2 in FY2025, a 600bps swing driven entirely by claims ratio compression (60.8 to 54.2). This is the best underwriting result in the dataset and signals disciplined reserving plus favorable loss trends.
- Canada operating income before tax surged 66.9% YoY to $2.66B on only 7.8% revenue growth, implying massive operating leverage as rate increases earned through while claims costs moderated. Canada now contributes 59% of segment operating income, up from ~47% two years ago.
- US segment operating income grew 23.2% YoY to $382M on just 5.6% revenue growth, with consistent margin expansion across all four years in the dataset. The US is quietly becoming a meaningful profit contributor with improving loss ratios.
- SBC-to-revenue at 0.16% is negligible for a $47B market cap company. Combined with a 1.4% buyback yield and 0.7% share count reduction, capital returns are genuine rather than offset by dilution. Total shareholder yield of 4.75% is real.
- Interest coverage at 28.5x with net debt of only $2B against ~$4B in unlevered FCF means the balance sheet is a source of optionality, not constraint. Debt paydown yield of 1% adds to total shareholder returns without sacrificing financial flexibility.
Risk Factors
- UK&I operating income dropped 25.6% YoY to $224M and the most recent quarter showed a $129M loss, a sharp reversal from $301M in FY2024. This segment represents 17% of premiums but is now destroying value on a quarterly run-rate basis.
- Expense ratio has crept higher every year, from 32.9 in FY2021 to 34.0 in FY2025. The combined ratio improvement is entirely claims-driven. If claims revert toward historical norms, there is no expense offset, and the 88.2 combined ratio could deteriorate quickly.
- Revenue growth has decelerated sharply: 5Y CAGR of 9.9% versus 3Y CAGR of 2.6% and YoY of 1.9%. The RSA acquisition in 2021 inflated the 5Y figure, and organic growth is now running in the low-to-mid single digits.
- EPS declined 1.4% YoY and EBITDA fell 10% YoY despite the strong combined ratio improvement. Investment income volatility in the corporate segment and the UK&I deterioration are masking what should be a much stronger earnings year from underwriting alone.
- Tangible book value per share of $66.71 versus price of $267 means the stock trades at 4x tangible book. Intangibles and goodwill represent 15.5% and 7.8% of assets respectively, reflecting acquisition-heavy growth that carries impairment risk if integration underperforms.
Power Corporation of Canada (TSX: POW)
$93.50
Overall Grade4.9 / 10
Power Corporation of Canada is a prominent holding company that operates primarily in the financial services sector across North America, Europe, and Asia. The company's business model revolves around capital allocation and managing its portfolio of financial franchises...
Grades
Valuation
Profitability
Growth
Debt
Dividend
Valuation
P/E21.2
P/B2.2
P/S1.2
P/FCF-
FCF Yield+0.0%
Growth & Outlook
Rev Growth (YoY)+3.3%
EPS Growth (YoY)-2.3%
Revenue 5yr-6.1%
EPS 5yr+1.1%
FCF 5yr-
Fundamentals
Market Cap$58.5B
Dividend Yield2.9%
Operating Margin+26.7%
ROE+10.2%
Interest Coverage15.1x
Competitive Edge
- Great-West Lifeco's scale in Canadian group benefits and U.S. retirement (Empower, the largest U.S. recordkeeper) creates distribution lock-in. Switching costs in employer-sponsored retirement plans are extremely high, providing durable fee streams.
- The Desmarais family's controlling interest aligns long-term capital allocation with patient value creation rather than quarter-to-quarter earnings management. This structure has historically supported countercyclical acquisitions at attractive prices.
- IGM Financial's advisory network (IG Wealth, Mackenzie) benefits from an aging Canadian population shifting toward wealth management. Fee-based AUM models are replacing transactional revenue, improving earnings visibility and margin stability.
- Power's growing alternative asset platforms (Sagard, Power Sustainable) position it to capture the institutional shift from public to private markets, a secular trend with higher fee rates and stickier capital than traditional asset management.
- Regulatory barriers in Canadian financial services limit new entrants. Power's subsidiaries operate under OSFI supervision with established capital buffers, creating a compliance moat that smaller competitors cannot easily replicate.
By the Numbers
- PEG of 0.31 is exceptionally low, with forward P/E compressing from 22x trailing to 15x on consensus EPS of $6.22 rising to $7.81 by Y3. That implies 25%+ EPS CAGR being priced at a discount typically reserved for no-growth financials.
- FCF payout ratio of 32% vs earnings payout ratio of 61% reveals strong cash conversion (FCF/NI of 1.08x). The dividend is covered nearly 3x by free cash flow, leaving substantial room for buybacks or debt reduction.
- Total AUM/AUA grew 14.7% YoY to $310.1B, accelerating from 12.6% the prior year. This organic growth engine compounds fee revenue without requiring proportional capital deployment, a high-quality earnings driver.
- TTM share repurchases of $2.5B represent roughly 4.3% of market cap, yet shares outstanding only declined 1%. Combined with the 2.9% dividend yield, total capital return is running near 7%, well covered by $10.5B in unlevered FCF.
- Interest coverage at 15x is very comfortable for a financial holding company. Net debt/EBITDA of 1.76x is moderate, and long-term debt to assets of just 2.2% at the holdco level signals conservative balance sheet management.
Risk Factors
- Revenue declined at a -7.7% 5-year CAGR and FCF contracted at -22.9% over 3 years. The IFRS 17 accounting transition distorts comparisons, but even adjusting for that, top-line momentum has been flat to negative on a multi-year basis.
- GBL segment swung to -$263M EBT loss in FY2025 from +$31M profit, a -948% decline. This European investment holding adds earnings volatility and opacity, dragging consolidated results while contributing minimal strategic synergy.
- Holding company costs are accelerating, with EBT losses widening from -$76M in FY2023 to -$236M in FY2025. That's a $160M annual drag increase, partially offsetting subsidiary earnings growth and signaling rising corporate overhead or investment spending.
- Tangible book value per share of $4.88 vs share price of $95.25 means the stock trades at nearly 20x tangible book. The $39.89 book value is heavily supported by intangibles and goodwill, creating impairment risk if acquisition returns disappoint.
- Estimated EBIT for Y1-Y3 is negative ($-1.4B range), which appears to reflect consolidation adjustments. Only 1 analyst covers revenue estimates, creating thin consensus and elevated estimate revision risk.
Insurance is one of those sectors where the business quality only becomes obvious during tough stretches. When everything’s going well, every insurer looks smart. It’s when claims spike, or rates reverse, or capital markets go sideways that you find out who actually knows what they’re doing. We’re not in a crisis, but the easy part of this cycle is behind us, and that’s when separation starts.
I think the biggest mistake investors make with this group is treating it as one trade. Buying “insurance exposure” as a block. The companies covered here have fundamentally different earnings profiles, different capital allocation philosophies, and different sensitivities to rates and credit. Owning the wrong one isn’t just a missed opportunity. It can actively drag your portfolio while the right pick compounds quietly beside it.
If I were building a position in this sector today, I’d be less focused on which name has run the most and more focused on which management teams have proven they can grow book value per share through full cycles. That’s the real scorecard in insurance. Everything else is noise.
